Atlas Trials

ZAP, US. Zomig for Appropriate for Primary Care

Clinical trial NCT00637286 · COMPLETED

Trial details

NCT number
NCT00637286
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Migraine
Start date
2004-07-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.